Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Respiratory Heterogeneity Shapes Biofilm Formation and Host Colonization in Uropathogenic Escherichia coli.

Beebout CJ, Eberly AR, Werby SH, Reasoner SA, Brannon JR, De S, Fitzgerald MJ, Huggins MM, Clayton DB, Cegelski L, Hadjifrangiskou M.

MBio. 2019 Apr 2;10(2). pii: e02400-18. doi: 10.1128/mBio.02400-18.

2.

Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Magana M, Sereti C, Ioannidis A, Mitchell CA, Ball AR, Magiorkinis E, Chatzipanagiotou S, Hamblin MR, Hadjifrangiskou M, Tegos GP.

Clin Microbiol Rev. 2018 Apr 4;31(3). pii: e00084-16. doi: 10.1128/CMR.00084-16. Print 2018 Jul. Review.

3.

A Dual Role for the Bacillus anthracis Master Virulence Regulator AtxA: Control of Sporulation and Anthrax Toxin Production.

Dale JL, Raynor MJ, Ty MC, Hadjifrangiskou M, Koehler TM.

Front Microbiol. 2018 Mar 15;9:482. doi: 10.3389/fmicb.2018.00482. eCollection 2018.

4.

Evidence of Cross-Regulation in Two Closely Related Pyruvate-Sensing Systems in Uropathogenic Escherichia coli.

Steiner BD, Eberly AR, Hurst MN, Zhang EW, Green HD, Behr S, Jung K, Hadjifrangiskou M.

J Membr Biol. 2018 Feb;251(1):65-74. doi: 10.1007/s00232-018-0014-2. Epub 2018 Jan 27.

5.

Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.

Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M.

Int J Mol Sci. 2017 Sep 30;18(10). pii: E2077. doi: 10.3390/ijms18102077.

6.

An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections.

Breland EJ, Eberly AR, Hadjifrangiskou M.

Front Cell Infect Microbiol. 2017 May 9;7:162. doi: 10.3389/fcimb.2017.00162. eCollection 2017. Review.

7.

Identification of a High-Affinity Pyruvate Receptor in Escherichia coli.

Behr S, Kristoficova I, Witting M, Breland EJ, Eberly AR, Sachs C, Schmitt-Kopplin P, Hadjifrangiskou M, Jung K.

Sci Rep. 2017 May 3;7(1):1388. doi: 10.1038/s41598-017-01410-2.

8.

The Histidine Residue of QseC Is Required for Canonical Signaling between QseB and PmrB in Uropathogenic Escherichia coli.

Breland EJ, Zhang EW, Bermudez T, Martinez CR 3rd, Hadjifrangiskou M.

J Bacteriol. 2017 Aug 22;199(18). pii: e00060-17. doi: 10.1128/JB.00060-17. Print 2017 Sep 15.

9.

Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli.

Abana CM, Brannon JR, Ebbott RA, Dunigan TL, Guckes KR, Fuseini H, Powers J, Rogers BR, Hadjifrangiskou M.

Microbiologyopen. 2017 Aug;6(4). doi: 10.1002/mbo3.466. Epub 2017 Mar 22.

10.

Signaling by two-component system noncognate partners promotes intrinsic tolerance to polymyxin B in uropathogenic Escherichia coli.

Guckes KR, Breland EJ, Zhang EW, Hanks SC, Gill NK, Algood HM, Schmitz JE, Stratton CW, Hadjifrangiskou M.

Sci Signal. 2017 Jan 10;10(461). pii: eaag1775. doi: 10.1126/scisignal.aag1775.

11.

Purine Biosynthesis Metabolically Constrains Intracellular Survival of Uropathogenic Escherichia coli.

Shaffer CL, Zhang EW, Dudley AG, Dixon BREA, Guckes KR, Breland EJ, Floyd KA, Casella DP, Algood HMS, Clayton DB, Hadjifrangiskou M.

Infect Immun. 2016 Dec 29;85(1). pii: e00471-16. doi: 10.1128/IAI.00471-16. Print 2017 Jan.

12.

The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Brannon JR, Hadjifrangiskou M.

Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016. Review.

13.

The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Floyd KA, Mitchell CA, Eberly AR, Colling SJ, Zhang EW, DePas W, Chapman MR, Conover M, Rogers BR, Hultgren SJ, Hadjifrangiskou M.

J Bacteriol. 2016 Sep 9;198(19):2662-72. doi: 10.1128/JB.00030-16. Print 2016 Oct 1.

14.

Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system.

Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, Hadjifrangiskou M, Peek RM.

Oncogene. 2016 Dec 1;35(48):6262-6269. doi: 10.1038/onc.2016.158. Epub 2016 May 9.

15.

Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens.

Shaffer CL, Good JA, Kumar S, Krishnan KS, Gaddy JA, Loh JT, Chappell J, Almqvist F, Cover TL, Hadjifrangiskou M.

MBio. 2016 Apr 26;7(2):e00221-16. doi: 10.1128/mBio.00221-16.

16.

Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.

Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ.

MBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16.

17.

The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment.

Floyd KA, Meyer AE, Nelson G, Hadjifrangiskou M.

Proteomics Clin Appl. 2015 Dec;9(11-12):990-1002. doi: 10.1002/prca.201500018. Epub 2015 Sep 13. Review.

PMID:
26255866
18.

Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili.

Floyd KA, Moore JL, Eberly AR, Good JA, Shaffer CL, Zaver H, Almqvist F, Skaar EP, Caprioli RM, Hadjifrangiskou M.

PLoS Pathog. 2015 Mar 4;11(3):e1004697. doi: 10.1371/journal.ppat.1004697. eCollection 2015 Mar.

19.

Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80. doi: 10.1073/pnas.1500374112. Epub 2015 Feb 9.

20.

Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli.

Greene SE, Pinkner JS, Chorell E, Dodson KW, Shaffer CL, Conover MS, Livny J, Hadjifrangiskou M, Almqvist F, Hultgren SJ.

MBio. 2014 Oct 28;5(6):e02038. doi: 10.1128/mBio.02038-14.

21.

Strong cross-system interactions drive the activation of the QseB response regulator in the absence of its cognate sensor.

Guckes KR, Kostakioti M, Breland EJ, Gu AP, Shaffer CL, Martinez CR 3rd, Hultgren SJ, Hadjifrangiskou M.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16592-7. doi: 10.1073/pnas.1315320110. Epub 2013 Sep 23.

22.

Escherichia coli biofilms have an organized and complex extracellular matrix structure.

Hung C, Zhou Y, Pinkner JS, Dodson KW, Crowley JR, Heuser J, Chapman MR, Hadjifrangiskou M, Henderson JP, Hultgren SJ.

MBio. 2013 Sep 10;4(5):e00645-13. doi: 10.1128/mBio.00645-13.

23.

Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Kostakioti M, Hadjifrangiskou M, Hultgren SJ.

Cold Spring Harb Perspect Med. 2013 Apr 1;3(4):a010306. doi: 10.1101/cshperspect.a010306. Review.

24.

Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics.

Kostakioti M, Hultgren SJ, Hadjifrangiskou M.

Virulence. 2012 Nov 15;3(7):592-4. doi: 10.4161/viru.22364. Epub 2012 Nov 15. No abstract available.

25.

Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.

Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ.

J Bacteriol. 2012 Nov;194(22):6195-205. doi: 10.1128/JB.01012-12. Epub 2012 Sep 14.

26.

Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ.

Infect Immun. 2012 Aug;80(8):2826-34. doi: 10.1128/IAI.00283-12. Epub 2012 Jun 4.

27.

What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli.

Hadjifrangiskou M, Hultgren SJ.

Virulence. 2012 May 1;3(3):231-3. doi: 10.4161/viru.19763. Epub 2012 May 1.

28.

Antitoxins: therapy for stressed bacteria.

Hadjifrangiskou M, Kostakioti M, Hultgren SJ.

Nat Chem Biol. 2011 Jun;7(6):345-7. doi: 10.1038/nchembio.584. No abstract available.

PMID:
21587255
29.

A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.

Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ.

Mol Microbiol. 2011 Jun;80(6):1516-29. doi: 10.1111/j.1365-2958.2011.07660.x. Epub 2011 May 5.

30.

QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli.

Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ.

Mol Microbiol. 2009 Sep;73(6):1020-31. doi: 10.1111/j.1365-2958.2009.06826.x. Epub 2009 Aug 23.

31.

Intrinsic curvature associated with the coordinately regulated anthrax toxin gene promoters.

Hadjifrangiskou M, Koehler TM.

Microbiology. 2008 Aug;154(Pt 8):2501-12. doi: 10.1099/mic.0.2007/016162-0.

32.

The alternative sigma factor sigmaH is required for toxin gene expression by Bacillus anthracis.

Hadjifrangiskou M, Chen Y, Koehler TM.

J Bacteriol. 2007 Mar;189(5):1874-83. Epub 2006 Dec 22.

Supplemental Content

Loading ...
Support Center